Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Abstract of presentation in January

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Dec 17, 2021 5:08pm

250 Views

Post# 34242246

RE:Abstract of presentation in January

Oh so they are releasing data a whole year later about ONE other patient. Meanwhile the search for patient 7 continues. Maybe next year we will get an update on patient 3 in January. I can see why no pharma wants to sign. .

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario